Immune BCG Market By Type ( 0.5 ml Package, 1 ml Package, 2 ml Package ), By Application ( FHospitals, Clinics ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 162
Immune BCG Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

BCG stands for Bacille Calmette-Guérin which is the most commonly used TB vaccine only currently available for being commercialized. BCG has been used for since 7 decades, but a very little about it is still known. As per a research, BCG vaccination which is done during infancy and adolescence can induce immunological memory to mycobacterial antigens which can help in maintaining the immunity of the very person. TB, which is caused by Mycobacterium tuberculosis, is the leading cause of human death, especially in the under-developed and developing countries. Recent advances in areas such as mycobacterial immunology and genomics have stimulated research on numerous new experimental vaccines, which will put forward futuristic opportunities for the very market to grow. Moreover, the relatively low cost of BCG vaccines, high safety, low side effects, and easy availability of this vaccine is a major driving factor for the market growth. However, the vague responses of the BCG vaccine on immunity might act as a challenge to the market growth. The report provides detailed qualitative and quantitative analysis of the Immune BCG Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Immune BCG Market Segmentation

By Type • 0.5 ml Package • 1 ml Package • 2 ml Package • Others By Application • Hospitals • Clinics • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. IMMUNE BCG MARKET OVERVIEW 2.1. IMMUNE BCG MARKET INTRODUCTION 2.2. GLOBAL IMMUNE BCG MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Immune BCG Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL IMMUNE BCG MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Immune BCG Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL IMMUNE BCG MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Immune BCG Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL IMMUNE BCG MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Immune BCG Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL IMMUNE BCG MARKET PRICE TREND, 2017-2025 2.6.1. Global Immune BCG Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL IMMUNE BCG MARKET BY TYPE, 2017-2025 3.1. 0.5 ML PACKAGE 3.2. 1 ML PACKAGE 3.3. 2 ML PACKAGE 3.4. OTHERS 3.5. GLOBAL IMMUNE BCG MARKET REVENUE BY TYPE, 2017-2025 3.5.1. Global Immune BCG Market Revenue (Million USD) and Share (%) By Type, 2017-2025 3.5.2. 0.5 ml Package Market Revenue and Growth Rate, 2017-2025 3.5.3. 1 ml Package Market Revenue and Growth Rate, 2017-2025 3.5.4. 2 ml Package Market Revenue and Growth Rate, 2017-2025 3.6. GLOBAL IMMUNE BCG MARKET PRODUCTION BY TYPE, 2017-2025 3.6.1. Global Immune BCG Market Production (Volume) and Share (%) By Type, 2017-2025 3.6.2. 0.5 ml Package Market Production and Growth Rate, 2017-2025 3.6.3. 1 ml Package Market Production and Growth Rate, 2017-2025 3.6.4. 2 ml Package Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other type segment. CHAPTER 4. GLOBAL IMMUNE BCG MARKET BY APPLICATION, 2017-2025 4.1. HOSPITALS 4.2. CLINICS 4.3. OTHERS 4.4. GLOBAL IMMUNE BCG MARKET REVENUE BY APPLICATION, 2017-2025 4.4.1. Global Immune BCG Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.4.2. Hospitals Market Revenue and Growth Rate, 2017-2025 4.4.3. Clinics Market Revenue and Growth Rate, 2017-2025 4.4.4. Others Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL IMMUNE BCG MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.5.1. Global Immune BCG Market Consumption (Volume) and share (%) By Application, 2017-2025 4.5.2. Hospitals Market Consumption and Growth Rate, 2017-2025 4.5.3. Clinics Market Consumption and Growth Rate, 2017-2025 4.5.4. Others Market Consumption and Growth Rate, 2017-2025 CHAPTER 5. GLOBAL IMMUNE BCG MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL IMMUNE BCG MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Immune BCG Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL IMMUNE BCG MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL IMMUNE BCG MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Immune BCG Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Immune BCG Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL IMMUNE BCG MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL IMMUNE BCG PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Immune BCG Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL IMMUNE BCG REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Immune BCG Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. IMMUNE BCG MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Immune BCG Market Share (%) of Top 3 Manufacturers 8.3.2. Immune BCG Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL IMMUNE BCG MANUFACTURERS ANALYSIS 9.1. MERCK 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Immune BCG Product Details 9.1.4. Merck Immune BCG Production, Revenue and Gross Margin 9.2. SANOFI PASTEUR 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Immune BCG Product Details 9.2.4. Sanofi Pasteur Immune BCG Production, Revenue and Gross Margin 9.3. JAPAN BCG LAB 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Immune BCG Product Details 9.3.4. Japan BCG Lab Immune BCG Production, Revenue and Gross Margin 9.4. CHINA NATIONAL BIOTEC 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Immune BCG Product Details 9.4.4. China National Biotec Immune BCG Production, Revenue and Gross Margin 9.5. SERUM INSTITUTE OF INDIA 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Immune BCG Product Details 9.5.4. Serum Institute of India Immune BCG Production, Revenue and Gross Margin 9.6. INTERVAX 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Immune BCG Product Details 9.6.4. Intervax Immune BCG Production, Revenue and Gross Margin 9.7. GSBPL 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Immune BCG Product Details 9.7.4. GSBPL Immune BCG Production, Revenue and Gross Margin CHAPTER 10. IMMUNE BCG MARKET VALUE CHAIN ANALYSIS 10.1. IMMUNE BCG INDUSTRIAL CHAIN ANALYSIS 10.2. IMMUNE BCG KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Merck
• Sanofi Pasteur
• Japan BCG Lab
• China National Biotec
• Serum Institute of India
• Intervax
• GSBPL

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS